A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people, with new generic versions priced at about $40 per patient per year.

Peter Mandelson has been stripped of voting rights and barred from taking dividends at the lobbying company he co-founded, as the Labour peer continues to suffer the fallout from his links to the late ...

Defense stocks rose anew across Europe and Asia on Wednesday after US President Donald Trump said NATO countries should shoot ...

The Fund generated a solid return of +1.18% in the second quarter, outperforming the Bloomberg U.S. Treasury Bills 3-6 Months ...

Germany is seeking to attract skilled Indian workers, its envoy said, as US President Donald Trump’s H-1B visa crackdown ...

The capacity of the global oil refining sector contracted by 350,000 barrels per day in the second quarter of 2025 on the closure of PetroChina’s Dalian plant and Petroineos’s Grangemouth plant. While ...

German business confidence unexpectedly dropped, highlighting the fragility of Chancellor Friedrich Merz’s plan to restore ...

Alibaba Group Holding Ltd.’s shares surged to their highest in nearly four years after revealing plans to ramp up AI spending ...

Virtus Seix shares Q2 bond market insights amid tariff shocks, yield swings, and fund positioning. Learn how they’re ...